Objective: To screen mutations in FERM domain-containing protein 7 (FRMD7) gene in two Chinese families with X-linked idiopathic congenital nystagmus (XLICN). Methods: Common ophthalmic data and peripheral blood of two Chinese XLICN families (families A and B) were collected after informed consent. Genomic DNA was prepared from the peripheral blood of members of the two families and from 100 normal controls. Mutations in the FRMD7 gene were determined by directly sequencing polymerase chain reaction (PCR) products. Results: We identified a novel mutation c.980_983delATTA compound with c.986C>A mutation in the 11th exon of FRMD7 in family B, and a previously reported splicing mutation c.782G>C (p.R261G) in family A. The mutations were detected in patients and female carriers, while they were absent in other relatives or in the 100 normal controls. Conclusions: Our results expand the spectrum of FRMD7 mutations in association with XLICN, and further confirm that the mutations of FRMD7 are the underlying molecular mechanism for XLICN.
Introduction
Idiopathic congenital nystagmus (ICN) is primarily an oculomotor disorder characterized by bilateral involuntary, periodic, and predominantly ocular oscillations. The symptoms usually present at birth, or develop within the first three months of life.
ICN has been found to be the most common type of nystagmus, and the prevalence of ICN is 1.9/10 000 in Leicestershire and Rutland, UK (Sarvananthan et al., 2009) . Unlike "sensory defect nystagmus", ICN is independent of any other visual or neurological abnormality.
ICN may be inherited as autosomal dominant (OMIM 164100) (Patton et al., 1993; Kerrison et al., 1998; Klein et al., 1998) , autosomal recessive (OMIM 257400) (Tarpey et al., 2006) , or X-linked (OMIM 310700) (Kerrison et al., 1999; Tarpey et al., 2006) . However, the most common mode of inheritance is X-linked, which can be either dominant or recessive, and X-linked loci have been mapped to chromosomes Xq26-q27 (Cabot et al., 1999) , Xp22 (Bassi et al., 1995) , and Xp11.3-p11.4 (Kerrison et al., 1999) . There are two genes that have been identified as disease-causing genes for X-linked ICN (XLICN). GPR143 maps to Xp22, and mutations within it are reported to cause ocular albinism type 1 (OA1), where nystagmus results as a secondary phenotype (Bassi et al., 1995) . Four-point-one ezrin, radixin, moesin (FERM) domain-containing protein 7 (FRMD7) resides at Xq26-q27, and mutations within it are approximately responsible for the 50% of ICN families (Tarpey et al., 2006) . However, there have been no responsible genes identified yet from the Xp11.3-p11.4.
In this study, we detected a novel mutation c.980_983delATTA compound with c.986C>A mutation in the 11th exon of FRMD7 in a three-generation Chinese XLICN family B, and a previously reported splicing mutation c.782G>C (p.R261G) (Zhang B. et al., 2007) in another four-generation Chinese XLICN family A. The mutations in FRMD7 were detected in the patients and carriers, while it was not detected in other healthy family members or in the 100 normal controls. These findings expand on the spectrum of FRMD7 mutations causing XLICN.
Materials and methods

Patients' data
Forty barley varieties were chosen for this study. Among these accessions, 12 are malting barley varieties released in recent years in China, and 28 are cultivated barley varieties collected from different countries, including the parental lines of several mapping populations and some commercial varieties imported to China as malt barley. Two XLICN families (families A and B) were recruited for this study from the Eye Center of the Second Affiliated Hospital of Zhejiang University, Hangzhou, China. Two patients (IV: 2, IV: 9), one carrier (III: 4), and one healthy member (IV: 10) from family A participated in the study (Fig. 1) . Two patients (III: 1, III: 3), three carriers (II: 2, II: 4, III: 2), and two healthy members (II: 1, III: 5) from family B participated in the study (Fig. 1) . Common ophthalmologic and orthoptic examinations were performed on all participants, including best corrected visual acuity in each eye, slit lamp biomicroscopy, fundus examination, ocular motor examination for strabismus, and binocular sensorial testing. Written consents were obtained from all participants according to the Declaration of Helsinki.
Genomic DNA preparation
Peripheral blood specimens (5 ml) were collected in an ethylenediamine tetraacetic acid (EDTA) coated vacutainer (Becton-Dickinson, Franklin Lakes, NJ, USA). We extracted genomic DNA in the peripheral blood leukocytes using a Simgen blood DNA mini kit (Simgen, Hangzhou, China).
Genetic analysis
The 12 exons and flanking intron sequences of FRMD7 were amplified by the polymerase chain reaction (PCR), using previously reported primers The squares represent the males, the circles indicate females, the black-filled symbols signify the affected individuals, the dotted circles indicate the female carriers, and a diagonal line through a symbol represents a deceased family member. The proband is denoted by a black arrow (Du et al., 2011; Hu et al., 2012) . PCR was performed in a volume of 25 μl in a DNA thermal cycler (Perkin Elmer, Norwalk, CT, USA) with primers listed in Table 1 . PCR cycling conditions were as follows: 5 min at 95 °C, followed by 10 cycles of touchdown PCR with 1 °C reduction per cycle from 60 °C to 50 °C, followed by 30 cycles with denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s, and extension at 72 °C for 45 s with a final extension step at 72 °C for 10 min. PCR products were isolated by electrophoresis on 1% agarose gels and sequenced using the BigDye terminator cycle sequencing kit V 3.1 (ABI Applied Biosystems; Sangon Co., China) on an ABI PRISM 3730 sequence analyzer, according to the manufacturer's instructions.
Results
Clinical findings
Two Chinese families with XLICN were analyzed. No male-to-male transmission was observed. The clinical data of the participants from families A and B are shown in Table 2 . In the four-generation Chinese family A (from the Zhejiang province), eight of the sixty-five living family members are affected, including six males and two females. In addition, three females are obligate unaffected carriers. The proband of family A is a seven-year-old boy (family A, individual IV: 2) who has had nystagmus since four or five months after birth. He has a horizontal jerk ocular oscillation without head posture. TTTGCTATTGTTGTCCCTTGAG  58  459  2  CGTGCTGCAGTATCAGGTTAG  CCCTACATACCTAGCTGCAAAC  58  243  3  TGACATTGCTGTTTGTTTCTACC  TCTCAAAGCCCTTTTCTCCC  60  304  4  GAGGGGACGGAAGAGGAGAGC  GGCATAACCCCCAAGTGGATAC  61  450  5  ATCTTGGATCTGGGAGAAGG  GCTTGGTTCTCTACCTGGC  58  238  6  GAGGACAAGGGTATGCTGGA  TCAGGTTTAAGGGCTTGCTC  58  281  7  GAGCTCTCAGGGTGGAAATG  ACACCCAAGTTTGAGCCAAG  58  293  8  GGCGGTCCCTCTCATTAAG  AAACGATTTGCAGAAACAACC  60  275  9  TTGGGATTTGAAGGTCTTTG  TCCTAAGCCTCCTGTGTTATTG  58  301  10+11  TTTAGTAGCCTATTGGTTTATGGC  TCAATTCATGGAAGCATTTG  58  401  12a  GAGGCTAATTTAGATCCCTCCC  CTGGCTTCATTGCAGTGGG  61  620  12b  TATGTGGACAAGCCACCCC  CTTCAGCAGTTGGTGTGTTG  61  613  12c  TGAATCAGAGATTCTTAAACCA  ACTGGGCCCCACACAAATAG  61  649 The best corrected visual acuity of both eyes at distance is 0.2 [in the unit of logarithm of the minimum angle of resolution (logMAR)]. Another affected member of family A (IV: 9) is twenty-six years old with nystagmus since he was four or five months old. He has a horizontal ocular oscillation with little head posture and head shaking, and his best corrected visual acuity for both eyes is 0.1 (in logMAR unit). In family A, the penetrance appears to be complete in males and about 40% in females.
In the three-generation Chinese family B (from the Jiangxi Province), two males (III: 1, III: 3) of the eighteen living family members are affected. In addition, three females (II: 2, II: 4, III: 2) are obligate unaffected carriers. The proband of family B is a fourteen-year-old boy (family B, individual III: 1) who has had nystagmus since four or five months after birth. He has a horizontal jerk ocular oscillation, with face turn to right and the null point to the left. The corrected visual acuity of both eyes at distance with the comfortable head posture is 0.3 (in logMAR unit). His sister and mother are asymptomatic obligate carriers.
Mutation detected in FRMD7
Direct sequencing analysis detected a previously reported splicing mutation in family A, c.782G>C (p.R261G) (Zhang B. et al., 2007) , at the 9th exon of FRMD7 in affected individuals (Fig. 2) . This splice-site mutation results in substitution of the
Fig. 2 Sequence analysis of an affected male (top), a normal individual (bottom), a carrier female (middle) from families A and B
Two types of FRMD7 mutations were identified in two families, which were previously reported splicing mutation c.782G>C (p.R261G) in family A, and novel mutation c.980_983delATTA compound with c.986C>A mutation in the 11th exon of FRMD7 in family B arginine residue at codon 261 by a glycine residue (p.R261G). Direct sequencing analysis in family B detected a novel mutation c.980_983delATTA compound with c.986C>A mutation in the 11th exon of FRMD7. This mutation results in substitution of the proline residue at codon 329 by a glutamine residue (p.P329E) and a frame-shift at codon 327 and a putative stop codon 26 amino acids downstream in the translated protein (p.H327PfsX353). These two mutations were confirmed, and were further extended to other family members. These two mutations in FRMD7 were not found in the unaffected members of the family or in the 100 unrelated controls.
Discussion
The human FRMD7 gene comprises 12 exons spanning approximately 51 kb on chromosome Xq26-q27, and encodes a 714-residue polypeptide. FRMD7 is a member of the super 4.1 family of proteins (Chishti et al., 1998) , and shares an FERM domain at its NH 2 -terminus (Tarpey et al., 2006) with band 4.1, ezrin, moesin, radixin, talin, filopodin, and merlin. The FERM domain of FRMD7 is located between residues 2 and 282, and the FERM adjacent (FA) domain (FERM-adjacent region) is located between residues 288 and 336 (Fig. 3) .
The FERM domain has a three-lobed 'cloverleaf' structure; each lobe represents a compactly folded structure. Lobe F1 (FERM-N, N-terminal FERM domain) has a fold resembling ubiquitin; lobe F2 (FERM-M) resembles acyl-CoA binding proteins; and lobe F3 (FERM-C, C-terminal actin-binding domain) has a fold related to pleckstrin homology domain/phosphotyrosine-binding domain (PTB) (Hamada et al., 2000; Han et al., 2000; Pearson et al., 2000; Shimizu et al., 2002; Smith et al., 2003) . The close packing of these domains suggests that they do not function independently, but rather form a co-ordinated structure (Baines, 2006) . The conserved ezrin/radixin/ moesin (ERM) proteins often organize membranecytoskeletal interactions (Tsukita and Yonemura, 1999) , and share a C-terminal actin-binding domain and an N-terminal FERM domain that binds membrane proteins (Mcclatchey and Fehon, 2009) , also acting as scaffolding for adaptor and signaling molecules (Mcclatchey and Fehon, 2009 ). (Tarpey et al., 2006; Schorderet et al., 2007; Self et al., 2007; Shiels et al., 2007; Zhang B. et al., 2007; He et al., 2008a; Kaplan et al., 2008; Li et al., 2008a; Du et al., 2011; Khan et al., 2011; Thomas et al., 2011; Hu et al., 2012; Radhakrishna et al., 2012) and the novel mutation in this study within FRMD7 has been indicated (Note: for interpretation of the references to color in this figure legend, the reader is referred to the web version of this article)
The FA domain is found next to the FERM domains, and defines a subset of FERM-containing proteins. The conservation of motifs in this region that are potential substrates for kinases, together with the known regulatory phosphorylation of 4.1R in this region, raises the possibility that the FA domain is a regulatory adaptation in this subset of the FERM proteins (Baines, 2006) .
To date, 48 mutations in FRMD7 have been reported worldwide in families with XLICN from various ethnic backgrounds (Fig. 3) (Tarpey et al., 2006; Schorderet et al., 2007; Self et al., 2007; Shiels et al., 2007; Zhang B. et al., 2007; He et al., 2008a; Kaplan et al., 2008; Li et al., 2008a; Du et al., 2011; Khan et al., 2011; Thomas et al., 2011; Hu et al., 2012; Radhakrishna et al., 2012) . These mutations include missense, nonsense, splicing mutations, insertions, and deletions. Just under half of the mutations (43%) identified within FRMD7 are predicted to cause gross defects at the protein level due to the introduction of frameshifts, nonsense mutations, and/or aberrant splicing. The other 57% of the mutations identified within FRMD7 are missense mutations.
In the present study, we found a novel mutation, c.980_983delATTA compound with c.986C>A mutation, in a three-generation Chinese XLICN family B. The mutations in FRMD7 were detected in the patients and carriers and were not detected in other healthy family members or in 100 normal controls. This supports that the identified mutations cause the pathogenesis of XLICN.
The novel mutation c.980_983delATTA (p.H32 7PfsX353) compound with c.986C>A (p.P329E) mutation locates at the 11th exon of FRMD7 gene, and results in substitution of the proline residue at codon 329 by a glutamine residue causing a frameshift at codon 327 and a putative stop at codon 26 amino acids downstream in the translated protein in the FA domain of FRMD7. These two changes alter the length of the open reading frame, creating a FRMD7 with an aberrant truncated FA domain. Since the FA domain is thought to be a regulatory adaptation in the FERM proteins, the aberrant truncated FA domain was considered to seriously affect the conservation of motifs in the FA region that are potential substrates for kinases, together with the known regulatory phosphorylation of 4.1R in this region. The FA region is immediately adjacent to FERM domains in all cases, is phosphorylated in vivo by protein kinase A (PKA) and protein kinase C (PKC), and regulates the activities of their neighboring FERM domain (Baines, 2006) . FRMD7 protein expression may play an important role in regulating neuronal development, particularly in regions of the brain associated with ocular motor control (Betts-Henderson et al., 2010) . Therefore, the aberrant truncated FA domain caused by the novel mutation may induce XLICN by affecting the activities of the FERM domain protein.
The underlying molecular mechanisms for XLICN are not fully understood, but it is anticipated that the spectrum of FRMD7 mutations will provide insights into this condition and the functioning and development of the visual pathways.
Our results expand the spectrum of FRMD7 mutations in association with XLICN, and further confirm that the mutations of FRMD7 are the underlying molecular mechanism for XLICN.
